These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3522061)

  • 1. [Comparison of nadolol and chlorthalidone in hypertensive subjects resistant to therapy with only captopril].
    De Cesaris R; Ranieri G; Chiarappa R; Balestrazzi M; Antoncecchi E
    Clin Ter; 1986 Mar; 116(6):465-71. PubMed ID: 3522061
    [No Abstract]   [Full Text] [Related]  

  • 2. [Controlled study of the antihypertensive efficacy of the combination of nadolol and bendroflumethiazide with respect to nadolol alone and placebo].
    Cherchi A; Sau F; Mercuro G; Seguro C; Lai O
    Clin Ter; 1985 May; 113(4):301-6. PubMed ID: 3893868
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of essential arterial hypertension with nadolol and bendroflumethiazide].
    Marchetta F; Chiarini C; Degli Esposti E; Santoro A; Sturani A; Zuccalà A; Zucchelli P
    Clin Ter; 1983 Aug; 106(3):209-12. PubMed ID: 6627892
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Jamaican hypertensives with atenolol and chlorthalidone.
    Grell GA; Alleyne GA; Robinson HM; Anderson M
    West Indian Med J; 1981 Sep; 30(3):124-8. PubMed ID: 7293174
    [No Abstract]   [Full Text] [Related]  

  • 5. [Our experience on the clinical use of nadolol].
    Trinchero R; Moratti M; Ghisio A; Pomari F; Artesani S; Barbano G
    Minerva Cardioangiol; 1985 Oct; 33(10):629-34. PubMed ID: 2867492
    [No Abstract]   [Full Text] [Related]  

  • 6. [Antihypertensive effect of metoprolol in essential hypertension].
    Rodríguez Rodríguez FJ; Petersen Guitarte G; Paumard Fraguas A; López-Vidriero E; Franco Manera R
    Med Clin (Barc); 1983 Mar; 80(8):358-61. PubMed ID: 6855321
    [No Abstract]   [Full Text] [Related]  

  • 7. [Regression of left ventricular hypertrophy by a prolonged anti-hypertensive treatment].
    Sonaglioni G; Floris B; Franchetta G; Palestini N; Verdecchia P
    G Ital Cardiol; 1982; 12(6):428-35. PubMed ID: 6219030
    [No Abstract]   [Full Text] [Related]  

  • 8. [Clinical experience with a new antihypertensive drug (captopril SQ 14.225), an oral inhibitor of converting enzyme].
    Santucci A; Aguglia F; Ficara C
    Clin Ter; 1981 Apr; 97(1):43-58. PubMed ID: 6269793
    [No Abstract]   [Full Text] [Related]  

  • 9. The management of severe hypertension with minoxidil in a once-a-day treatment regimen.
    Nicholson GD; Fraser HS; Hassell TA; Bayley A
    J Clin Hypertens; 1985 Dec; 1(4):295-303. PubMed ID: 3836299
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The antihypertensive effect of a new beta-adrenergic blocking drug metroprolol in combination with chlorthalidone].
    Jäättelä A; Pyöräiä K
    Duodecim; 1976; 92(11):597-603. PubMed ID: 7445
    [No Abstract]   [Full Text] [Related]  

  • 11. Minoxidil in a once-a-day step-3 antihypertensive program.
    Oh MS; Uribarri J; Alveranga D; Bazilinski N; Lazar I; Carroll HJ
    J Clin Hypertens; 1985 Mar; 1(1):23-9. PubMed ID: 3836295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractory hypertension.
    Gillum RF
    J Natl Med Assoc; 1984 Nov; 76(11):1048. PubMed ID: 6502722
    [No Abstract]   [Full Text] [Related]  

  • 13. Treatment of portal hypertension with nadolol in patients with liver cirrhosis.
    Cervera J; Torres-Zamora M; Gutiérrez-Carreño R; Fierro M; Schaeffer L; Landa L
    Arch Invest Med (Mex); 1983; 14(4):331-41. PubMed ID: 6678555
    [No Abstract]   [Full Text] [Related]  

  • 14. [Reduction of hypertensive changes in the electrocardiogram during antihypertensive treatment].
    Patzschke U; Manegold C; Wolff G
    MMW Munch Med Wochenschr; 1979 Jun; 121(23):795-7. PubMed ID: 111073
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of hypertensive hyperuricemic patients with a new beta blocker-diuretic combination].
    Brandstetter G; Hoffmann H
    Wien Klin Wochenschr; 1984 Sep; 96(18):696-9. PubMed ID: 6240831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of clonidin and chlorthalidone on blood pressure and glucose tolerance in hypertensive patients.
    Sung PK; Samet P; Yeh BK
    Curr Ther Res Clin Exp; 1971 May; 13(5):280-5. PubMed ID: 4998390
    [No Abstract]   [Full Text] [Related]  

  • 17. Drug treatment of essential hypertension. Practical guidelines.
    Dirix R; Savoye D; Tyberghein JM
    Practitioner; 1979 May; 222(1331):713-6. PubMed ID: 482222
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of chronic treatment with a non-selective beta-adrenoceptor antagonist on the enteroinsular axis and intermediary metabolites.
    Peden NR; Dow RJ; Isles TE; Martin BT; Yee KF; Buchanan KD
    Diabetes Res; 1985 May; 2(3):135-9. PubMed ID: 3905182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic and clinical outcomes in nondiabetic individuals with the metabolic syndrome assigned to chlorthalidone, amlodipine, or lisinopril as initial treatment for hypertension: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Black HR; Davis B; Barzilay J; Nwachuku C; Baimbridge C; Marginean H; Wright JT; Basile J; Wong ND; Whelton P; Dart RA; Thadani U;
    Diabetes Care; 2008 Feb; 31(2):353-60. PubMed ID: 18000186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study of the combination of chlorthalidone with verapamil and metoprolol in arterial hypertension: evaluation by cycloergometrics].
    Candau LA; Pereira LS; Scherr C
    Arq Bras Cardiol; 1981 Aug; 37(2):133-8. PubMed ID: 6753801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.